Given the widespread use of GLP-1 agonists for both on and off-label uses, increased awareness of TIND among clinicians is essential for prompt recognition, accurate diagnosis, and the initiation of treatment to mitigate the potential for significant and prolonged morbidity
The risks of IGF-1 application The relationship between IGF-1 and cellular senescence is still unclear and controversial
Timing Your Medications: Best Practices for Safe Combination Therapy The FDA-recommended approach is to take levothyroxine on an empty stomach, ideally 30 to 60 minutes before breakfast
Patients carrying specific GLP1R variants may exhibit heightened receptor sensitivity, increasing both the likelihood of GI side effects and the potential for symptom improvement
Sofinicline, a novel nicotinic agonist believed to augment CHRNA expression, is currently being tested for ADHD but appears promising in metabolic syndrome, T2DM, and eating disorders (124126)
Follow-up You will normally be given a follow-up appointment to see me as you might not remember the explanation given at the Endoscopy Unit due to the effects of the sedative